Working to Eradicate Gynecologic Cancers

Nadim Bou Zgheib, MD

Gynecology Oncology Fellow
University of South Florida College of Medicine
12902 Magnolia Dr
SRB
Tampa, FL
USA 33612


Biographical Sketch:
I'm a 2nd year fellow in gyn onc at the University of South Florida. My 1st year of fellowship was a basic science and translational research. Gynecol Oncol 2009. 114:3; 427-430.Surgical Pathology Clinics, Current Concept in Gynecologic Pathology: Epithelial tumor of the Genital Tract. Clinical Ovarian Cancer, Vol. 4, No. 1, 7-11. Gynecol Oncol. 2012 Jan;124(1):119-24.Int J OF ONCOL 41: 179-188, 2012, Gynecol Cancer. 2012 Jul;22(6):960-7. In addition i had 2 posters 1 plenary session at SGO 2012"

Papers:
54 - Featured Poster Development of a Rucaparib response signature that shows in vitro predictive value to the PARP inhibitors, ABT-888 and Olaparib in ovarian cancer cells 146 - Poster Session A The BCL2 antagonist of cell death (BAD) signaling pathway and phospho-BAD protein levels are associated with triple-negative breast cancer clinical development and clinical outcome 214 - Poster Session A BCL2 antagonist of cell death (BAD) gene sequence and functional analysis of phosphorylation sites in ovarian cancer 299 - Poster Session A Copy number variation and mutations associated with ovarian cancer chemoresponse 301 - Poster Session A HSP90 inhibition decreases ovarian cancer cell proliferation and potentiates platinum sensitivity 455 - Poster Session B Polyphyllin D, a Chinese herb, potentiates cisplatin-induced death in ovarian cancer cell lines